<DOC>
	<DOCNO>NCT01389102</DOCNO>
	<brief_summary>Estradiol treatment effective reduce vasomotor symptom ( eg hot flush ) postmenopausal woman . This study evaluate safety efficacy Evamist .</brief_summary>
	<brief_title>Estradiol Transdermal Spray Treatment Vasomotor Symptoms</brief_title>
	<detailed_description>Multicenter , randomize , double-blind , placebo-controlled trial evaluate different dos transdermal estradiol deliver sray symptomatic postmenopausal woman . The endpoint reduction frequency severity hot flush .</detailed_description>
	<mesh_term>Hot Flashes</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>Post menopausal woman , Ages 35 older , Frequent moderate severe hot flush , Qualifying general medical health Disqualifying gynecological disorder , Disqualifying dermatological disorder , Disqualifying concurrent condition</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Postmenopause</keyword>
	<keyword>Hot Flashes</keyword>
	<keyword>Estradiol</keyword>
	<keyword>Polyestradiol phosphate</keyword>
	<keyword>Estradiol valerate</keyword>
	<keyword>Estradiol 3-benzoate</keyword>
	<keyword>Estradiol 17 beta-cypionate</keyword>
	<keyword>Estrogens</keyword>
	<keyword>Hormones</keyword>
	<keyword>Hormones , Hormone Substitutes</keyword>
	<keyword>Hormone Antagonists</keyword>
</DOC>